IRYCIS Outstanding publication

• Tuesday, 24 June 2025

  Gallego M, Botella LM, Mascaraque M, Nicolás J, Albiñana V, Abarca E, Gilaberte Y, González S, Juarranz Á, Carrasco E. N-acetylcysteine and raloxifene boost photodynamic therapy against cutaneous squamous cell carcinoma by decreasing TGFβ1 secreted by cancer-associated fibroblasts

  Int J Biol Sci. 2025

  10.7150/ijbs.106642

• Tuesday, 17 June 2025

  Cortés A, Serrano JJ, Cordero D, Menacho M, del Rey JM, Del Campo L, Saavedra C, Chamorro J, Rosero D, Sotoca P, Guillén C, Guerra E, Fernández M, López E, Martínez N, Gion M, Salazar MT, Agudo P, Garrido P, Alonso GL. Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study

  Oncologist. 2024

  10.1093/oncolo/oyae299

• Tuesday, 10 June 2025

  Jiménez D, Dubois-Silva Á, Demelo-Rodríguez P, Ruiz-Artacho P, López-Núñez JJ, Moisés J, Muriel A, Bura-Riviere A, Mahé I, Barillari G, Bikdeli B, Monreal M and the RIETE Investigators. Acute pulmonary embolism: a multimarker calculator to predict short-term outcomes

  European Heart Journal. 2025

  10.1093/eurheartj/ehaf228

• Tuesday, 3 June 2025

  Ron R, Martínez J, Herrera S, Ramos L, Díez A, Sainz T, Álvarez N, Correa A, Muriel A, López J, Pérez JA, Moreno S, Serrano S. CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis

  Front Immunol. 2024

  10.3389/fimmu.2024.1343124